Clinical Trial Information Request for Protocol 25-570 Title A randomized, placebo-controlled, double-blind Phase 3 trial comparing, relative to placebo, the effect of Kinisoquin on thromboembolic events in patients with metastatic pancreatic cancer (CATIQ P3) PI Site Directions: Type your name, contact email and phone number (optional) into the boxes below then click Save to Submit your request for information about this study. Name Email Phone